PPIB and cancer: This notion is also supported by a previous study showing that b-AP15 sensitized cancer cells to killing by T and NK cells in vitro, which occurs in part through TRAIL-mediated apoptosis, and b-AP15 pre-treatment followed by infusion of either NK or T cells significantly delayed tumor progression in tumor-bearing mice23.